Table of Contents: Volume 12, Issue #23

Listen to the latest oncology-focused research published in this week’s issue of Oncotarget, Volume 12, Issue 23. https://www.oncotarget.com/archive/v12/i23/ Research Paper (Cover) - “Anaplastic lymphoma kinase rearrangement prevalence in patients with advanced non-small cell lung cancer in the United States – retrospective real world data” https://doi.org/10.18632/oncotarget.28114 News - “Excitement for our future” https://doi.org/10.18632/oncotarget.28116 (PDF Download) Editorial - “Interferon-γ/IRF-1 pathway regulatory mechanisms of PD-L1 expression and relevance for immune checkpoint blockade in hepatocellular carcinoma (HCC)” https://doi.org/10.18632/oncotarget.27995 (PDF Download) Editorial - “Results from a randomized trial combining trastuzumab with a peptide vaccine suggest a role for HER2-targeted therapy in triple-negative breast cancer” https://doi.org/10.18632/oncotarget.27998 (PDF Download) Keywords - ALK rearrangement, non-small cell lung cancer (NSCLC), prevalence, multi-omics, molecular signatures, BRCA, HER2, triple negative breast cancer, breast cancer, hepatocellular carcinoma, cancer, science, research, oncology About Oncotarget Oncotarget is a bi-weekly, peer-reviewed, open access biomedical journal covering research on all aspects of oncology. To learn more about Oncotarget, please visit https://www.oncotarget.com/ or connect with: SoundCloud - https://soundcloud.com/oncotarget Facebook - https://www.facebook.com/Oncotarget/ Twitter - https://twitter.com/oncotarget LinkedIn - https://www.linkedin.com/company/oncotarget Instagram - https://www.instagram.com/oncotargetjrnl/ YouTube - https://www.youtube.com/oncotargetyoutube Pinterest - https://www.pinterest.com/oncotarget/ Reddit - https://www.reddit.com/user/Oncotarget Oncotarget is published by Impact Journals, LLC. Please visit https://www.impactjournals.com/ or connect with @ImpactJrnls Media Contact MEDIA@IMPACTJOURNALS.COM 18009220957